The weight-loss pharmaceutical industry, led by companies such as Eli Lilly, has become a significant sector in Ireland, now accounting for 20% of the country's goods exports. However, some reports suggest that the rapid growth of this industry may be at risk due to a potential "bubble effect". The industry's expansion is expected to continue, with new weight-loss drugs potentially reshaping the global obesity fight.